KMT2D and urinary bladder cancer: Whole-exome sequencing demonstrated that the mutation frequency of chromatin remodeling genes in bladder cancer was more than 10%, including KDM6A, MLL2 (also known as KMT2D), CREBBP, EP300, and ARID1A [6].